Systemic inflammation, oxidative stress and apolipoprotein B/A1 ratio in active psoriasis: bridging an apparent paradox


  • Rahul Saxena Department of Biochemistry, SAHS, Sharda University, Greater Noida, New Delhi, India
  • Shilpa Suneja Department of Biochemistry, VMMC & Safdarjung Hospital, New Delhi, India
  • Raj Saxena Department of Clinical Research, Sikkim Manipal University, Manipal, India
  • Dilutpal Sharma Department of Biochemistry, Kings George Medical College, Lucknow, UP, India
  • Alok Milton Lal Department of Biochemistry & Biochemical Engineering, JSB &B, SHIATS, Allahabad, UP, India



C- reactive protein, Total cholesterol, Malondialdehyde, HDL-cholesterol, LDL-cholesterol


Background: Psoriasis is characterized by systemic increase of inflammation and oxidative stress. In addition, increased incidence of dyslipidemia in dermatological disorders is also in alarming phase. It is conceivable that association of inflammation, oxidative stress and dyslipidemia enhances the future the risk of cardiovascular disease (CVD) in psoriasis patients. The main of the study is to estimate the marker of systemic inflammation, oxidative stress, plasma lipid profile and apolipoprotein levels in psoriasis patients and to determine their role in predicting CVD risk in psoriasis.

Methods: The study population consist of subjects categorized into two groups; Group I: Healthy controls and Group II: Psoriasis patients (n= 25 in each group). Erythrocyte malondialdehyde (MDA), plasma C-reactive protein (CRP) and lipid profile along with apolipoprotein B and A1 were measured and statistically analyzed using standard methods.

Results: Plasma CRP, total cholesterol, triglycerides, LDL-cholesterol and MDA levels were significantly high (p<0.05) in patient group as compared to healthy controls. HDL-cholesterol levels were altered insignificantly (p<0.1) in patient group. Plasma Apo B/Apo A1 ratio were increased significantly (p<0.01) in patient groups as compared to controls.

Conclusions: Thus, enhanced inflammation, oxidative stress along with increase in Apo B, A1 and its ratio authenticates the fact that these markers are more efficient in prediction of CVD risk in psoriasis patients than conventional lipid profile parameters.


Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829-35.

Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W and Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet .2001;358: 2026-33.

Rocha-Pereiraa P, Santos-Silvac A, Rebeloc I, Figueiredoe A, Quintanilha A , Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clinica Chimica Acta. 2001;303:33-9.

Orem A, Deger O, Cimsit G, Bahadir S. Plasma polymorphonuclear leukocyte elastase levels and its relation to disease activity in psoriasis. Clin Chim Acta. 1997;264:49-54.

Rocha-Pereira P, Rebelo I, Santos-Silva A, Figueiredo A, Ferra MIA, Quintanilha A et al. Leukocyte activation and oxidative stress in psoriasis. Br J Pharmacol. 1999;127:83.

Paller D, Petrou I. Pediatric psoriasis: C-reactive protein levels associated with disease severity. J Invest Dermatol. 2009;102:219–27.

Bhattacharya I, Saxena R, Gupta V. Efficacy of vitamin E in knee osteoarthritis management of North Indian Geriatric population. Therap Adv Musculo Dis. 2012;4(1):11-9.

Singh S, Saxena R, Lal AM. Influence of aging on plasma ascorbate level. Natl Acad Sci Lett. 2005;28(3&4):125-7.

Shoe M, Jackson C and Yu BP. Lipid peroxidation contributes to age related membrane rigidity. Free Rad Bio Med. 1995;18:977-84.

Saxena R, Bhattacharya I, Saxena, R. Susceptibility of Knee Osteoarthritic patients to develop Cardiovascular disease. Asian J Medical Sciences. 2013;4(3):62-8.

Isha, Jain VK, Lal H. C-Reactive Protein and Uric Acid Levels in Patients with Psoriasis. Ind J Clin Biochem. 2011;26(3):309-11.

Kökçam I, Naziroğlu M. Antioxidants and lipid peroxidation status in the blood of patients with psoriasis. Clin Chim Acta. 1999;289(1-2):23-3.

Toker A, Kadi M, Yildirim AK, Aksoy H, Akçay F. Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct. 2009;27(3):176-80.

Friedewald WT, Levy RI and Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972,18:499-502.

Sinnhuber RO, Yu TC, Yu TC. Characterization of the red pigment formed in the thiobarbituric acid determination of oxidative rancidity. Food Res. 1958;23:626-30.

Gisondi P, Ferrazzi A, Girolomoni G. Metabolic comorbidities and psoriasis. Acta Dermatovenerol Croat. 2010;18:297-304.

Hahn BH, Grossman J, Chen W, Mc Mahon M. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemia. J Autoimmun. 2007;28:69-75.

Saxena R, Mehrotra V. Prediction of hypertension and cardiovascular disease risk in North Indian geriatric population: a conundrum of senescence. Int J Comm Med Public Health. 2014;1(1):18-23.

Dutta J, Sharma D, Saxena R. Oxidative stress mediated electrolyte imbalance in 30 known cases of knee osteoarthritis patients: A clinical approach. Asian J Medical Sciences. 2015;6(5):26-30.






Original Research Articles